Your browser doesn't support javascript.
loading
Lessons from mouse models in the impact of risk factors on the genesis of childhood B-cell leukemia.
Casado-García, Ana; Isidro-Hernández, Marta; Alemán-Arteaga, Silvia; Ruiz-Corzo, Belén; Riesco, Susana; Prieto-Matos, Pablo; Sánchez, Lucía; Sánchez-García, Isidro; Vicente-Dueñas, Carolina.
Afiliación
  • Casado-García A; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Salamanca, Salamanca, Spain.
  • Isidro-Hernández M; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Alemán-Arteaga S; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Salamanca, Salamanca, Spain.
  • Ruiz-Corzo B; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Riesco S; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Salamanca, Salamanca, Spain.
  • Prieto-Matos P; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Sánchez L; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Salamanca, Salamanca, Spain.
  • Sánchez-García I; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Vicente-Dueñas C; Department of Pediatrics, Hospital Universitario de Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Front Immunol ; 14: 1285743, 2023.
Article en En | MEDLINE | ID: mdl-37901253
ABSTRACT
B-cell acute lymphoblastic leukemia (B-ALL) stands as the primary contributor to childhood cancer-related mortality on a global scale. The development of the most conventional forms of this disease has been proposed to be conducted by two different steps influenced by different types of risk factors. The first step is led by a genetic insult that is presumably acquired before birth that transforms a healthy cell into a preleukemic one, which is maintained untransformed until the second step takes place. This necessary next step to leukemia development will be triggered by different risk factors to which children are exposed after birth. Murine models that recap the stepwise progression of B-ALL have been instrumental in identifying environmental and genetic factors that contribute to disease risk. Recent evidence from these models has demonstrated that specific environmental risk factors, such as common infections or gut microbiome dysbiosis, induce immune stress, driving the transformation of preleukemic cells, and harboring genetic alterations, into fully transformed leukemic cells. Such models serve as valuable tools for investigating the mechanisms underlying preleukemic events and can aid in the development of preventive approaches for leukemia in child. Here, we discuss the existing knowledge, learned from mouse models, of the impact of genetic and environmental risk factors on childhood B-ALL evolution and how B-ALL prevention could be reached by interfering with preleukemic cells.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia de Células B / Leucemia Linfocítica Crónica de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Animals / Child / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia de Células B / Leucemia Linfocítica Crónica de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Animals / Child / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: España